Reports for NATCO PHARMA (CANADA) INC
Company Name
NATCO PHARMA (CANADA) INC
Totals |
||
Shortage reports |
26 |
|
| Actual shortage: | 10 (38%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 16 (62%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
1 (4%) |
|
Overdue reports |
5 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAT-QUETIAPINE | 150MG | TABLET | Resolved | 2019-04-23 | 2021-10-31 | 82236 |
| NAT-QUETIAPINE | 150MG | TABLET | Actual shortage | 2024-04-29 | 2024-04-30 | 226594 |
| NAT-QUETIAPINE | 200MG | TABLET | Resolved | 2019-04-17 | 2022-07-01 | 81903 |
| NAT-QUETIAPINE | 300MG | TABLET | Resolved | 2019-04-17 | 2022-07-01 | 81906 |
| NAT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-11-23 | 2019-02-07 | 67512 |
| NAT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-11-23 | 2019-02-07 | 67515 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0